| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $132.38B | -7.5% |
| Cost of Revenue | $116.09B | -10.7% |
| R&D Expense | $6.0M | -60.0% |
| SG&A Expense | $2.44B | -13.4% |
| Interest Expense | $1.04B | +14.6% |
| Income Tax | $892.0M | +78.4% |
| Net Income | $4.40B | +108.0% |
| EPS (Basic) | $10.82 | +116.0% |
| EPS (Diluted) | $10.79 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.12B | -35.8% |
| Accounts Receivable | $9.77B | -11.4% |
| Inventory | $5.10B | +27.6% |
| Current Assets | $17.27B | -3.6% |
| Total Assets | $73.68B | +1.5% |
| Current Liabilities | $13.33B | -11.7% |
| Long-term Debt | $18.68B | +2.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.96B | +18.4% |
| Investing Cash Flow | -$2.10B | +14.9% |
| Financing Cash Flow | -$3.54B | -7.0% |
| +116.2% |
| Total Liabilities |
| $43.44B |
| -1.5% |
| Stockholders' Equity | $29.09B | +6.1% |